Literature DB >> 34596414

Talaromynoids A-I, Highly Oxygenated Meroterpenoids from the Marine-Derived Fungus Talaromyces purpureogenus SCSIO 41517 and Their Lipid Accumulation Inhibitory Activities.

Zhong-Hui Huang1, Xiao Liang1, Chan-Juan Li2, Qiong Gu3, Xuan Ma1, Shu-Hua Qi1,4.   

Abstract

Nine new highly oxygenated 3,5-dimethylorsellinic acid-derived meroterpenoids, talaromynoids A-I (1-9), were isolated from the marine-derived fungus Talaromyces purpureogenus SCSIO 41517. Their structures including absolute configurations were elucidated by HRMS, NMR, single-crystal X-ray diffraction analysis, and electronic circular dichroism calculations. Compounds 1 and 7-9 possessed unprecedented 5/7/6/5/6/6, 6/7/6/6/6/5, 6/7/6/5/6/5/4, and 7/6/5/6/5/4 polycyclic systems, respectively. Biologically, compound 5 showed selective inhibitory activity against phosphatase CDC25B with an IC50 value of 13 μM. Moreover, 7-9 and 12 exhibited the activity of reducing triglyceride in 3T3-L1 adipocytes in a dosage-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34596414     DOI: 10.1021/acs.jnatprod.1c00681

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

1.  Characterization of a bioactive meroterpenoid isolated from the marine-derived fungus Talaromyces sp.

Authors:  Xuan Hong; Xiaoqing Guan; Qiliang Lai; Dehua Yu; Zhongwei Chen; Xiaoteng Fu; Beibei Zhang; Changkun Chen; Zongze Shao; Jinmei Xia; Jiang-Jiang Qin; Weiyi Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-04-13       Impact factor: 4.813

2.  New Antibacterial Secondary Metabolites from a Marine-Derived Talaromyces sp. Strain BTBU20213036.

Authors:  Fuhang Song; Yifei Dong; Shangzhu Wei; Xinwan Zhang; Kai Zhang; Xiuli Xu
Journal:  Antibiotics (Basel)       Date:  2022-02-10

3.  New Secondary Metabolites from the Marine-Derived Fungus Talaromyces mangshanicus BTBU20211089.

Authors:  Kai Zhang; Xinwan Zhang; Rui Lin; Haijin Yang; Fuhang Song; Xiuli Xu; Long Wang
Journal:  Mar Drugs       Date:  2022-01-18       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.